Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients (Q38005811)

From Wikidata
Jump to navigation Jump to search
scientific article published on 24 April 2012
edit
Language Label Description Also known as
English
Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients
scientific article published on 24 April 2012

    Statements

    Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients (English)
    0 references
    Filip Baert
    Elien Glorieus
    Cathérine Reenaers
    Harald Peeters
    Dennis Franchimont
    Olivier Dewit
    Philippe Caenepeel
    BIRD (Belgian IBD Research and Development)
    24 April 2012
    154-160

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit